New tool measures thyroid cancer patients' anxiety

Researchers at Cedars-Sinai have developed the Thyroid Cancer Modified Anxiety Scale (TC-MAX) to measure anxiety levels in thyroid cancer patients. The tool aims to help clinicians better align treatment plans with patient psychological needs and preferences.
Why it matters
Integrating psychological assessment into cancer care can improve patient outcomes and ensure treatment decisions are better tailored to individual distress levels.
edited by Sadie Harley , reviewed by Robert Egan
This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:
Add as preferred source Credit: SHVETS production from Pexels A new tool created by Cedars-Sinai Health Sciences University investigators is the first to measure anxiety in patients with thyroid cancer. Described in the journal Thyroid , the Thyroid Cancer Modified Anxiety Scale (TC-MAX) could help doctors clarify patients' expectations, better match treatment to their needs and improve patient outcomes.
"A patient's distress greatly influences which thyroid cancer treatment the patient prefers and what their doctor recommends," said Allen Ho, MD, professor of surgery, co-director of the Thyroid Cancer Program at Cedars-Sinai Cancer and senior author of the study.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in